Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through ...
What is the current share price of Vertex Pharmaceuticals (VRTX)? Vertex Pharmaceuticals's (VRTX) current share price is $488.25. This constitutes a price movement of 0.99% when compared to the share ...
My CF consists of two very rare genetic mutations. We had all heard of Trikafta being around the corner, but I had been told so many times that it wasn’t designed for someone with my mutations. So, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback